São Paulo Civil Servants Investigated for Selling Illegal Paraguayan Mounjaro

Brazilian authorities are investigating civil servants from the São Paulo city government for allegedly selling illegally imported Mounjaro (tirzepatide), a diabetes and weight-loss drug, sourced from Paraguay. The investigation was launched by the São Paulo Civil Police after a tip-off revealed that public employees were using their positions to facilitate the sale of the unregulated medication. Mounjaro, manufactured by Eli Lilly, is not approved for sale in Brazil, making its import and distribution illegal. The suspects face charges of drug trafficking and administrative misconduct. The case highlights growing concerns over the black market for weight-loss drugs in Brazil, driven by high demand and limited access to approved alternatives. No arrests have been made yet, but the investigation is ongoing.

Global Impact

This case reflects a broader global trend of black markets emerging for GLP-1 receptor agonists like Mounjaro and Ozempic, driven by soaring demand for weight-loss treatments. Economically, it pressures pharmaceutical companies like Eli Lilly to expand production and distribution in emerging markets, potentially lowering prices over time.